Scarica l'app Stockscreener
5.84
6.38%
0.35
Precedente Chiudi:
$5.49
Aprire:
$5.41
Volume 24 ore:
17.21M
Relative Volume:
4.14
Capitalizzazione di mercato:
$908.50M
Reddito:
$419.75M
Utile/perdita netta:
$-15.10M
Rapporto P/E:
-61.28
EPS:
-0.0953
Flusso di cassa netto:
$63.10M
1 W Prestazione:
+5.42%
1M Prestazione:
+12.09%
6M Prestazione:
-34.31%
1 anno Prestazione:
-48.86%
Intervallo 1D:
$5.41
$5.915
Intervallo di 1 settimana:
$5.305
$5.915
Portata 52W:
$4.45
$13.88
Certara Inc Stock (CERT) Company Profile
Nome
Certara Inc
Settore
Industria
Telefono
(415) 237-8272
Indirizzo
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT vs VEEV, BTSG, TEM, HQY, HNGE
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
5.84 | 908.50M | 419.75M | -15.10M | 63.10M | -0.0953 |
VEEV
Veeva Systems Inc
|
171.36 | 27.84B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
68.98 | 13.54B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
56.14 | 10.08B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.46 | 7.40B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
78.97 | 6.11B | 646.34M | -512.40M | 202.76M | -6.6871 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Downgrade | Barclays | Overweight → Equal Weight |
| 2026-02-27 | Downgrade | Craig Hallum | Buy → Hold |
| 2026-01-06 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-11-21 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-09-29 | Iniziato | Craig Hallum | Buy |
| 2025-07-03 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-08 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-09-27 | Aggiornamento | UBS | Neutral → Buy |
| 2024-04-10 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-04 | Iniziato | JMP Securities | Mkt Perform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-07 | Iniziato | UBS | Neutral |
| 2023-12-05 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2023-08-22 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-10 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-04-03 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-12-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-09-08 | Iniziato | Berenberg | Buy |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-01 | Iniziato | Piper Sandler | Overweight |
| 2022-01-11 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-08-05 | Ripresa | Credit Suisse | Neutral |
| 2021-07-23 | Iniziato | Robert W. Baird | Outperform |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-01-05 | Iniziato | BofA Securities | Buy |
| 2021-01-05 | Iniziato | Credit Suisse | Neutral |
| 2021-01-05 | Iniziato | Jefferies | Hold |
| 2021-01-05 | Iniziato | William Blair | Outperform |
Mostra tutto
Certara Inc Borsa (CERT) Ultime notizie
Price to book forward of Certara, Inc. – BMV:CERT - TradingView
Price to earnings forward of Certara, Inc. – BMV:CERT - TradingView
[Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Certara, Inc.CERT - PR Newswire
Certara, Inc. Actuals & Estimates (NASDAQ:CERT) - TradingView
CERT Forecast — Price Target — Prediction for 2027 - TradingView
Certara Launches Bio Venture Catalyst for Emerging Biotechs to De-Risk Investment and Accelerate Development - marketscreener.com
CERT Stock Slides As Certara Faces Probes And CFO Exit - timothysykes.com
Certara StockLaw Firm Launches Investigation After Share Price Slide - Ad-hoc-news.de
Certara names Faiz Mohammed interim CFO as John Gallagher steps down - MSN
Certara (CERT) Stock Sees Fair Value Edges Lower As Analysts Trim Targets - Yahoo Finance
Bragar Eagel & Squire, P.C. is Investigating Certara, Inc. - GlobeNewswire
(CERT) Volatility Zones as Tactical Triggers - Stock Traders Daily
Certara, Inc. Shareholders Are Encouraged to Reach Out to - GlobeNewswire
Certara Appoints Interim CFO Amid Leadership Transition - The Globe and Mail
Certara CFO John Gallagher to resign, reaffirms 2026 guidance By Investing.com - Investing.com India
SMID Core Equity Portfolio's Certara Inc(CERT) Holding History - GuruFocus
Certara (CERT) CFO John Gallagher Announces Resignation, Interim Successor Appointed - GuruFocus
Certara Announces CFO Transition, Names Interim CFO, and Reaffirms 2026 Financial Guidance - Minichart
Certara (CERT) CFO John Gallagher to Resign in 2026, Interim Suc - GuruFocus
Certara CFO John Gallagher to resign, reaffirms 2026 guidance - Investing.com
Certara Announces CFO Transition - The Manila Times
CFO transition at Certara (NASDAQ: CERT) as company reaffirms 2026 guidance - Stock Titan
Certara names interim CFO as John Gallagher plans July exit - Stock Titan
Certara Inc (CERT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Certara Inc (CERT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Certara Inc (CERT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Certara Inc (CERT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Certara Inc (CERT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Certara Inc (CERT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Certara Inc (CERT) Institutional Confidence - TradingKey
Certara Inc (CERT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Certara Inc (CERT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Certara, Inc. Hits Day High with 16.12% Surge in Stock Price - MarketsMojo
Is It Time To Consider Buying Certara, Inc. (NASDAQ:CERT)? - simplywall.st
symbol__ Stock Quote Price and Forecast - CNN
Certara (CERT) Valuation Boosted by Simulations Plus Acquisition - GuruFocus
Certara outlines AI push, cost cuts and new growth engines at Jefferies conference - MSN
CERT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Certara Inc. (CERT) Q1 2026 Earnings: EPS Miss Weighs on Shares as Biosimulation Demand Remains SteadySpecial Dividend Alert - newsline.com
CERT Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesMid-Term Outlook - newsline.com
Certara Q1 2026 Earnings: EPS Misses Estimates, Stock Slips as Revenue Details Remain UnclearDividend Increase Stocks - newsline.com
Certara Inc. (CERT) Q1 2026 Earnings: EPS Misses Estimates, Shares Rise on Mixed SignalsDividend Earnings Report - newsline.com
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Inve - GuruFocus
CERT Investors Have Opportunity to Join Certara, Inc. Fraud Investigation with the Schall Law Firm - Morningstar
Certara Company Profile & Introduction - Moomoo
Price-Driven Insight from (CERT) for Rule-Based Strategy - Stock Traders Daily
Certara Inc Azioni (CERT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):